MedPath

Innovation in Endobronchial Sampling

Conditions
Diffuse Interstitial Lung Disease
Interventions
Procedure: Advanced endoscopic imaging modalities
Registration Number
NCT02380326
Lead Sponsor
KU Leuven
Brief Summary

Evaluating an integrated diagnostic work-up of virtual navigation bronchoscopy (VNB), confocal laser endomicroscopy and micro computerized tomography (micro-CT) in the diagnostic path of pulmonary lesions in the non-oncological patient.

Detailed Description

The region(s) of interest that has/have to be sampled, will be selected upfront. Guided by the endobronchial pathway that is created by virtual bronchoscopy, the flexible bronchoscope will be navigated to the regions of interest and an optical biopsy of the region will be obtained using pCLE. One biopsy sample will be processed in the endoscopy suite to be able to prepare it for micro-CT analysis.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Presence of diffuse pulmonary disease necessitating bronchoscopic evaluation.
  • Informed consent available
  • Age > 18
  • FVC > 50%pred
  • DLCO > 35%pred
  • PaO2 > 55 mmHg, pCO2 < 45 mmHg (ambient air)
  • No exclusion criteria
Exclusion Criteria
  • Age > 75
  • Systolic arterial pressure in the pulmonary artery : PAPS >40mmHg
  • Platelet count <100000/µl
  • INR > 1.4
  • BMI >30
  • Diffuse bullous lung disease
  • Active anti-platelet or anticoagulant treatment
  • Active heart failure or unstable coronary heart disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Diffuse intersitial lung diseaseAdvanced endoscopic imaging modalitiesPatients suffering from diffuse intersitial lung disease without a certain diagnosis subjected to advanced endoscopic imaging modalities
Lung transplant recipientsAdvanced endoscopic imaging modalitiesLung transplant recipients with diffuse parenchymal abnormalities subjected to advanced endoscopic imaging modalities
Primary Outcome Measures
NameTimeMethod
Diagnostic yieldpostprocedural
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath